Increases in CD4 T Lymphocytes with Intermittent Courses of Interleukin-2 in Patients with Human Immunodeficiency Virus Infection — A Preliminary Study

1995427 citationsJournal Articlebronze Open Access

Authors

Joseph A. Kovacs · Cardinal Glennon Children’s Medical Center

Michael Baseler

Robin Dewar

Susan Vogel · National Institute of Allergy and Infectious Diseases

Richard T. Davey

Judith Falloon · National Institute of Allergy and Infectious Diseases

Michael A. Polis · National Institute of Allergy and Infectious Diseases

Robert Walker ·

Abstract

Intermittent courses of interleukin-2 can improve some of the immunologic abnormalities associated with HIV infection in patients with more than 200 CD4 cells per cubic millimeter.

Topics & Keywords

HIV Research and Treatment Immune Cell Function and Interaction HIV-related health complications and treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 332, Issue 9, pp. 567-575

DOI: 10.1056/nejm199503023320904

Field-Weighted Citation Impact: 14.51